Masimo Stork

FDA 510(k) K234021 · Masimo Corporation

Substantially Equivalent

510(k) numberK234021

Submission

Device name
Masimo Stork
Applicant
Masimo Corporation
Irvine, CA, US
Received
December 20, 2023
Decision date
May 3, 2024
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QYU – Infant Pulse Rate And Oxygen Saturation Monitor For Over-The-Counter Use
Device class
Class II (moderate risk)
Regulation
21 CFR 870.2705
Specialty
Cardiovascular

An infant pulse rate and oxygen saturation monitor for over-the-counter use is a device that uses photoplethysmography to measure pulse rate and oxygen saturation in infants. The device may contain alarms that alert the caregiver when vital sign(s) go outside preset threshold(s).

More from Masimo Corporation

510(k)DeviceDecision
K253417Masimo Root Monitoring SystemMWI · Traditional 08/12/2026SE
K260880SedLine Sedation MonitorOLW · Traditional 07/10/2026SE
K254209Radius VSM and AccessoriesMHX · Traditional 06/04/2026SE
K243324Masimo O3 Regional OximeterMUD · Traditional 07/17/2025SE
K250757Radius VSM and AccessoriesMHX · Traditional 05/29/2025SE
K243305Masimo W1DPS · Traditional 04/03/2025SE
K240229Masimo W1DPS · Traditional 08/08/2024SE
K214115MightySat -OTCOLK · Traditional 01/31/2024SE
K223721Masimo StorkDQA · Traditional 12/15/2023SE
K232512Masimo W1DPS · Traditional 11/17/2023SE

Questions and answers

When was Masimo Stork cleared by the FDA?

Masimo Stork (K234021) received a 510(k) decision of Substantially Equivalent on May 3, 2024, 135 days after the submission was received.

What is the product code of K234021?

The FDA product code is QYU – Infant Pulse Rate And Oxygen Saturation Monitor For Over-The-Counter Use, a Class II (moderate risk) device regulated under 21 CFR 870.2705.